Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lasofoxifene Tartrate

Known as: (-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol D-tartrate (1:1) (salt) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The invention provides a preparation method of a lasofoxifene tartrate intermediate compound, which comprises the following steps… Expand
Is this relevant?
2013
2013
The present invention provides a process for preparing intermediates lasofoxifene tartrate, the method by synthesizing 6-alkoxy-2… Expand
Is this relevant?
2011
2011
6-Methoxy-1-tetralone was condensed with 1-[2-(4-bromophenoxy)ethyl]pyrrolidine,followed by bromination with pyridinium bromide… Expand
Is this relevant?
2010
2010
 
Is this relevant?
2007
2007
A dissolution method with high performance liquid chromatography (HPLC) analysis was validated for an immediate release low dose… Expand
Is this relevant?
Review
2006
Review
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
2006
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
2005
2005
Gateways to Clinical Trials is a guide to the most recent clinical trials reported in current literature and congresses. The data… Expand
Is this relevant?
2005
2005
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
2005
2005
Gateways to Clinical Trials are a guide to the most recent clinical trials in the current literature and congresses. The data in… Expand
Is this relevant?